Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuangshuang Xing

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Frontiers in Plant Science|May 8, 2023
Efficient Windows malware identification and classification scheme for plant protection information systemsZhiguo Chen, Shuangshuang Xing, Xuanyu Ren
International Journal of Nursing Sciences|October 10, 2025
Time series analysis of outpatient blood collection visits: Fluctuation patterns and nursing staff allocation optimizationShuangshuang Xing, Xiarong Du, Yan Hu, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|February 15, 2024
Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trialShuangshuang Xing, Yiqin Pu, Xiaoqian Zhao, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Frontiers in Plant Science|May 8, 2023
Efficient Windows malware identification and classification scheme for plant protection information systemsZhiguo Chen, Shuangshuang Xing, Xuanyu Ren
International Journal of Nursing Sciences|October 10, 2025
Time series analysis of outpatient blood collection visits: Fluctuation patterns and nursing staff allocation optimizationShuangshuang Xing, Xiarong Du, Yan Hu, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|February 15, 2024
Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trialShuangshuang Xing, Yiqin Pu, Xiaoqian Zhao, et al.
Pageof 1